For health care professionals only

The information contained on this site is intended for use only by health care professionals in the United States. Countries outside of the United States may have different regulatory requirements or medical practices than the United States. Therefore, this information may not be appropriate for use outside of the United States.

Are you a health care professional in the United States?

You will now be leaving the NovoSeven® RT website.

Congenital Factor VII Deficiency

NovoSeven® RT is effective in stopping bleeds in people with congenital Factor VII (FVII) deficiency

  • NovoSeven® RT replaces FVII Factor VII (seven)
    One of the 13 clotting factor proteins that help form blood clots.
    during clotting Clotting
    The process of forming into a clot or clots.
    to treat bleeds Bleed
    In hemophilia, a collection of blood in an area, such as a muscle or joint.
    from
    Factor VII deficiency Factor VII (seven) deficiency
    A rare bleeding disorder in which the blood has low levels of Factor VII. Factor VII is important in the blood-clotting process because it binds to blood cells near the location of an injury and to activated platelets, setting the clotting process in motion.
  • NovoSeven® RT works at the site of the injury to help form a stable clot Clot
    The thickened mass of blood and cells your body forms to stop the bleeding at the place where you have been injured.

What is congenital FVII deficiency?

Congenital Factor VII deficiency Congenital Factor VII (seven) deficiency
A bleeding disorder in which there are low levels of FVII in the blood.
is a bleeding disorder in which there are low levels of FVII in the blood. FVII plays an important role in the blood-clotting Blood-clotting
Also known as coagulation. It is the process of turning some of the elements in the blood into a clot. Blood-clotting is the result of a sequence of actions and reactions that involve several different proteins in the blood.
process. When there is not enough FVII in the blood, clotting can take much longer than normal or may not occur at all.

  • FVII deficiency is rare, affecting an estimated 1 in 500,000 people
  • Mild-to-moderate FVII deficiency is marked by increased bleeding after surgery and trauma
  • Severe FVII deficiency is marked by spontaneous Spontaneous
    Something that happens on its own, for what seems like no reason. Spontaneous bleeding does not appear to have a specific cause.
    , severe, and even life-threatening bleeding

What causes congenital FVII deficiency?

Congenital FVII deficiency is caused by an abnormal Abnormal
Something that is not normal. For example, abnormal bleeding.
gene Gene
A section of DNA. Each gene on a strand of DNA contains certain genetic traits that have been passed on from parents to child.
that is inherited by a child from both parents.

Who gets congenital FVII deficiency?

The affected FVII gene is not linked to gender. Men and women have an equal chance of being born with FVII deficiency.

Signs of congenital FVII deficiency

The most common signs of congenital FVII deficiency, other than excessive Excessive
Too much of something or more of something than is thought to be normal. For example, too much bleeding.
bleeding after injury or invasive procedures Invasive procedure
Most often referred to as surgery, because the doctor enters the body through an incision to repair damage.
, include:

  • Frequent nosebleeds
  • Bleeding from the gums
  • Very heavy, prolonged menstrual Menstrual
    The menstrual cycle consists of a number of bodily changes associated with the development of an egg and the possibility of pregnancy.
    bleeding
  • Head bleeds in newborns
  • Heavier-than-normal bleeding at circumcision Circumcision
    Removal of a man’s foreskin.
  • Intestinal bleeding

FVII deficiency can be detected at birth. However, some people with FVII deficiency grow into adulthood without knowing they have it. The blood test that confirms FVII deficiency is called a clotting assay Clotting assay
A blood test to determine what specific bleeding disorder a person has, based on a prolonged PT or PTT previously measured.
. It measures the amount of time it takes to create a clot.